Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Ion Channel Modulators Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Channel Blockers
  • 1.3.3 Channel Openers
• 1.4 Market Segment by Application
  • 1.4.1 Global Ion Channel Modulators Market Share by Application (2019-2025)
  • 1.4.2 Clinical Trials
  • 1.4.3 Hospital
  • 1.4.4 Other
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Ion Channel Modulators Market Size
  • 2.1.1 Global Ion Channel Modulators Revenue 2014-2025
  • 2.1.2 Global Ion Channel Modulators Sales 2014-2025
• 2.2 Ion Channel Modulators Growth Rate by Regions
  • 2.2.1 Global Ion Channel Modulators Sales by Regions 2014-2019
  • 2.2.2 Global Ion Channel Modulators Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Ion Channel Modulators Sales by Manufacturers
  • 3.1.1 Ion Channel Modulators Sales by Manufacturers 2014-2019
  • 3.1.2 Ion Channel Modulators Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Ion Channel Modulators Revenue by Manufacturers (2014-2019)
  • 3.2.2 Ion Channel Modulators Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Ion Channel Modulators Market Concentration Ratio (CR5 and HHI)
• 3.3 Ion Channel Modulators Price by Manufacturers
• 3.4 Key Manufacturers Ion Channel Modulators Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Ion Channel Modulators Market
• 3.6 Key Manufacturers Ion Channel Modulators Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Channel Blockers Sales and Revenue (2014-2019)
  • 4.1.2 Channel Openers Sales and Revenue (2014-2019)
• 4.2 Global Ion Channel Modulators Sales Market Share by Type
• 4.3 Global Ion Channel Modulators Revenue Market Share by Type
• 4.4 Ion Channel Modulators Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Ion Channel Modulators Sales by Application

6 United States

• 6.1 United States Ion Channel Modulators Breakdown Data by Company
• 6.2 United States Ion Channel Modulators Breakdown Data by Type
• 6.3 United States Ion Channel Modulators Breakdown Data by Application

7 European Union

• 7.1 European Union Ion Channel Modulators Breakdown Data by Company
• 7.2 European Union Ion Channel Modulators Breakdown Data by Type
• 7.3 European Union Ion Channel Modulators Breakdown Data by Application

8 China

• 8.1 China Ion Channel Modulators Breakdown Data by Company
• 8.2 China Ion Channel Modulators Breakdown Data by Type
• 8.3 China Ion Channel Modulators Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Ion Channel Modulators Breakdown Data by Company
• 9.2 Rest of World Ion Channel Modulators Breakdown Data by Type
• 9.3 Rest of World Ion Channel Modulators Breakdown Data by Application
• 9.4 Rest of World Ion Channel Modulators Breakdown Data by Countries
  • 9.4.1 Rest of World Ion Channel Modulators Sales by Countries
  • 9.4.2 Rest of World Ion Channel Modulators Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Pfizer, Inc. (US)
  • 10.1.1 Pfizer, Inc. (US) Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Ion Channel Modulators
  • 10.1.4 Ion Channel Modulators Product Introduction
  • 10.1.5 Pfizer, Inc. (US) Recent Development
• 10.2 Neusentis, Inc. (US)
  • 10.2.1 Neusentis, Inc. (US) Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Ion Channel Modulators
  • 10.2.4 Ion Channel Modulators Product Introduction
  • 10.2.5 Neusentis, Inc. (US) Recent Development
• 10.3 AstraZeneca (UK)
  • 10.3.1 AstraZeneca (UK) Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Ion Channel Modulators
  • 10.3.4 Ion Channel Modulators Product Introduction
  • 10.3.5 AstraZeneca (UK) Recent Development
• 10.4 Aurora Biomed, Inc. (Canada)
  • 10.4.1 Aurora Biomed, Inc. (Canada) Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Ion Channel Modulators
  • 10.4.4 Ion Channel Modulators Product Introduction
  • 10.4.5 Aurora Biomed, Inc. (Canada) Recent Development
• 10.5 CalciMedica, Inc. (US)
  • 10.5.1 CalciMedica, Inc. (US) Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Ion Channel Modulators
  • 10.5.4 Ion Channel Modulators Product Introduction
  • 10.5.5 CalciMedica, Inc. (US) Recent Development
• 10.6 Cellectricon AB (Sweden)
  • 10.6.1 Cellectricon AB (Sweden) Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Ion Channel Modulators
  • 10.6.4 Ion Channel Modulators Product Introduction
  • 10.6.5 Cellectricon AB (Sweden) Recent Development
• 10.7 Convergence Pharmaceuticals Limited (UK)
  • 10.7.1 Convergence Pharmaceuticals Limited (UK) Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Ion Channel Modulators
  • 10.7.4 Ion Channel Modulators Product Introduction
  • 10.7.5 Convergence Pharmaceuticals Limited (UK) Recent Development
• 10.8 Cytocentrics AG (Germany)
  • 10.8.1 Cytocentrics AG (Germany) Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Ion Channel Modulators
  • 10.8.4 Ion Channel Modulators Product Introduction
  • 10.8.5 Cytocentrics AG (Germany) Recent Development
• 10.9 Evotec AG (Germany)
  • 10.9.1 Evotec AG (Germany) Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Ion Channel Modulators
  • 10.9.4 Ion Channel Modulators Product Introduction
  • 10.9.5 Evotec AG (Germany) Recent Development
• 10.10 flyion GmbH (Germany)
  • 10.10.1 flyion GmbH (Germany) Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Ion Channel Modulators
  • 10.10.4 Ion Channel Modulators Product Introduction
  • 10.10.5 flyion GmbH (Germany) Recent Development
• 10.11 GlaxoSmithKline Plc. (UK)
• 10.12 Nanion Technologies GmbH (Germany)
• 10.13 NeuroSearch A/S (Denmark)
• 10.14 Novartis AG (Switzerland)
• 10.15 Parion Sciences, Inc. (US)
• 10.16 Sanofi (France)
• 10.17 Targacept, Inc. (US)
• 10.18 Xention Limited (UK)
• 10.19 Zalicus, Inc. (US)

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Ion Channel Modulators Sales Channels
  • 11.2.2 Ion Channel Modulators Distributors
• 11.3 Ion Channel Modulators Customers

12 Market Forecast

• 12.1 Global Ion Channel Modulators Sales and Revenue Forecast 2019-2025
• 12.2 Global Ion Channel Modulators Sales Forecast by Type
• 12.3 Global Ion Channel Modulators Sales Forecast by Application
• 12.4 Ion Channel Modulators Forecast by Regions
  • 12.4.1 Global Ion Channel Modulators Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Ion Channel Modulators Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

A ion channel modulator, or channel modulator, is a type of drug which modulates ion channels. They include channel blockers and channel openers.
In 2019, the market size of Ion Channel Modulators is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Ion Channel Modulators.

This report studies the global market size of Ion Channel Modulators, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Ion Channel Modulators sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Pfizer, Inc. (US)
Neusentis, Inc. (US)
AstraZeneca (UK)
Aurora Biomed, Inc. (Canada)
CalciMedica, Inc. (US)
Cellectricon AB (Sweden)
Convergence Pharmaceuticals Limited (UK)
Cytocentrics AG (Germany)
Evotec AG (Germany)
flyion GmbH (Germany)
GlaxoSmithKline Plc. (UK)
Nanion Technologies GmbH (Germany)
NeuroSearch A/S (Denmark)
Novartis AG (Switzerland)
Parion Sciences, Inc. (US)
Sanofi (France)
Targacept, Inc. (US)
Xention Limited (UK)
Zalicus, Inc. (US)

Market Segment by Product Type
Channel Blockers
Channel Openers

Market Segment by Application
Clinical Trials
Hospital
Other

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Ion Channel Modulators status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Ion Channel Modulators manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Ion Channel Modulators are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025